Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.
about
New developments in the pathology of malignant lymphoma: a review of the literature published from May 2015–September 2015The long non-coding RNA LINC01013 enhances invasion of human anaplastic large-cell lymphoma.Sweyjawbu expression is a predictor of ALK rearrangement status in lymphoma.Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive LymphomasCombating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells.Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experienceBasal autophagy is pivotal for Hodgkin and Reed-Sternberg cells' survival and growth revealing a new strategy for Hodgkin lymphoma treatmentThree-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance.Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer.ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman.Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia.Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.Targeting Autophagy in ALK-Associated Cancers.The potential role of HGF-MET signaling and autophagy in the war of Alectinib versus Crizotinib against ALK-positive NSCLC.A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy.Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma
P2860
Q26774077-51EB7B01-41D2-4B5B-9E02-3A2D0B7A26A1Q33670964-800FA596-B35B-4261-A0A8-4B34A6F1E515Q37702635-E72B17C8-CC9A-433D-AFBB-3F6471F2B581Q38644718-E8901F6B-1284-487A-8997-616FA08B8121Q38806238-FD39E873-7952-44FE-854E-27D27E37116BQ38949798-41FF5EF1-CF30-40B0-B0FD-C7BB74DCF92EQ40855242-5A21B12C-0937-401A-B903-BC9A14A1307AQ41168233-C9E4C075-7252-4883-B90F-491E8D081864Q41260025-60CD163A-6E41-4AB2-98A9-E407B148FF4EQ41840649-7B186A4C-1CDA-49BE-8884-40D129DC7214Q42517286-A547C939-5A01-4C24-9263-818148D5FC79Q47162451-B21D321F-F4BE-49B7-8A7A-FCF89A3EBDEAQ49545616-DEE1A5EC-6F59-459A-A8D3-78B4376AF2FFQ49795554-74F00CEC-241D-4FCB-A193-538AA3E90E62Q54110132-66F6A79C-57FB-4992-9377-8C01EC4C3909Q58779434-78B1ED03-6CC7-48E4-BD83-EB58AB43B584
P2860
Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting autophagy enhances t ...... naplastic large cell lymphoma.
@ast
Targeting autophagy enhances t ...... naplastic large cell lymphoma.
@en
type
label
Targeting autophagy enhances t ...... naplastic large cell lymphoma.
@ast
Targeting autophagy enhances t ...... naplastic large cell lymphoma.
@en
prefLabel
Targeting autophagy enhances t ...... naplastic large cell lymphoma.
@ast
Targeting autophagy enhances t ...... naplastic large cell lymphoma.
@en
P2093
P2860
P356
P1433
P1476
Targeting autophagy enhances t ...... naplastic large cell lymphoma.
@en
P2093
Aurore Desquesnes
Estelle Espinos
Fabienne Meggetto
Géraldine Mitou
Isabelle Beau
Julie Frentzel
Laurence Lamant
Patrice Codogno
Pierre Brousset
Sophie Le Gonidec
P2860
P304
30149-30164
P356
10.18632/ONCOTARGET.4999
P407
P577
2015-08-17T00:00:00Z